“Mylan Methotrexate Recall: Particulate Matter Hazard.” GovInfoNow, updated October 12, 2026. https://govinfonow.com/recall/44836-mylan-institutional-llc-recalls-methotrexate-injection-usp-50-mg-2. Based on FDA recall #D-1328-2015 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1328-2015%22&limit=1).
The FDA announced on March 18, 2015, that Mylan Institutional LLC is recalling Methotrexate Injection due to the presence of particulate matter. The Class I recall affects vials distributed nationwide and in Puerto Rico.
How to tell if you have it
Brand: Mylan
Product: Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL), 2 mL Single-dose Vial
Packaging: 5 x 2 mL vials per carton
NDC: 0069-0146-01 and 67457-467-99
Lot #: 7801082 (Exp. 07/15) and 7801421 (Exp. 09/16)
Quantity: 15,095 vials and 300 vials
The hazard
The recall addresses the presence of particulate matter in the Methotrexate Injection. The FDA classified this as a Class I hazard.
Context
GovInfoNow's records show Mylan Institutional LLC has 10 other recalls on record since January 23, 2015. Other recent recalls of similar products include Mylan Thiamine HCl Injection (May 3, 2021), Mylan Amiodarone Injection (August 17, 2020), and Mylan Daptomycin Injection (July 7, 2020). Other recent recalls of similar products include B. Braun Medical Lactated Ringer's Injection (August 12, 2026), Cipla Lanreotide Injection (January 2, 2026), and IMAAVY Injection (September 23, 2026).
How to tell if you have this one
Look for Methotrexate Injection, USP 50 mg/2 mL (25 mg/mL) in 2 mL single-dose vials. Check the lot numbers: 7801082 with expiration date 07/15, or 7801421 with expiration date 09/16. The product is labeled as distributed by Pfizer Labs (NDC 0069-0146-01) and manufactured for Mylan Institutional LLC (NDC 67457-467-99).
Brand
Mylan
Category
Drug
Based on the official FDA remedy
What to do — step by step
Check Lot Numbers
Verify if your vials match lot numbers 7801082 or 7801421.
Stop Using Affected Vials
Do not use any vials from the recalled lots due to the risk of particulate matter.
Where it went and when
Where it was distributed
Distributed nationwide.
Nationwide
Not listed
FDA distribution: “Nationwide and Puerto Rico” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 15 months after the firm started it.
1Firm started the recall
2FDA classified it Class I
3Published in FDA’s Enforcement Report
4FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #D-1328-2015 (March 18, 2015) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1328-2015 to see it in context.
Plain-language summary written by qwen3.6:35b-a3b on October 12, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.